A two-day meeting aimed at raising awareness among policymakers and public about rare diseases scheduled for the end of the ...

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory viruses, has been named acting director of the nearly $50 billion agency.

Using an arcane law, officials have effectively delayed funding from the National Institutes of Health, leaving medical ...

During the pandemic, Matthew Memoli, who has conducted research on influenza and other viruses, was also a vocal critic of Anthony Fauci, who for decades served as the director of the National ...

He then explains that Bobby Kennedy Jr believes deeply in NIH’s mission. As I told an NIH employee a short time ago, the claim that Kennedy believes deeply in NIH’s mission is ...

The Pentagon said it would fire 5,400 civilian probationary workers beginning next week, and officials say a wave of much ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research publications and public appearances.

A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can continue among the Trump administration's freeze on HHS activities.

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory viruses, has been named acting director of the nearly $50 billion agency.

The sudden policy change is that the NIH is to cap indirect cost recovery at 15 percent of the direct costs of a grant, ...